Stocks · Basic Materials · Chemicals - Specialty
Innospec Inc. IOSP
$97.41 +2.35% Close, Oct 2, 2026 · NASDAQ · Market cap $2.40B
Strong trendLow risk
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $4.90, up 544.7% year over year.
- Earnings beat analyst estimates in each of the last 7 quarters (average surprise over the last four: +12.9%).
- The stock is in an uptrend: above its 200-day average for 94 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Basic Materials sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 39%
- EPS growth (TTM, YoY)Top 2%
- FCF growth (TTM, YoY)Bottom 40%
- Revenue growth, 3-year CAGRBottom 41%
- Revenue growth accelerationTop 38%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 37%
- Gross marginTop 46%
- Operating marginBottom 48%
- Cash conversion (OCF / net income)Bottom 18%
- Accruals (lower is better)Bottom 16%
- Net debt / EBITDA (lower is better)Top 6%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 27%
- Free-cash-flow yieldBottom 43%
- EBITDA / enterprise valueTop 45%
- Sales / enterprise valueTop 29%
- P/E vs own 5-year history (lower is better)Top 36%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 39%
- 6-month returnTop 11%
- 1-year return vs S&P 500Top 28%
- Distance from 52-week highTop 1%
- Trend checklist (0–4)Top 4%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 30%
- Consecutive EPS beatsTop 5%
- Share of analysts rating BuyBottom 27%
- Upside to consensus price targetBottom 17%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 6%
- Maximum drawdown, 3 yearsTop 46%
- Beta vs S&P 500 (lower is better)Top 45%
- Net debt / EBITDA (lower is better)Top 6%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 0.2% | 2.9% | ↑ |
| EPS growth (YoY) | 333.0% | 544.7% | ↑ |
| Gross margin | 28.4% | 27.5% | ↓ |
| Operating margin | 9.1% | 8.1% | ↓ |
| FCF margin | 4.9% | 3.5% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 2.9% | 0.2% | ↑ | Bottom 39% |
| EPS growth (TTM, YoY) | 544.7% | 333.0% | ↑ | Top 2% |
| Gross margin | 27.5% | 28.4% | ↓ | Top 46% |
| Operating margin | 8.1% | 9.1% | ↓ | Bottom 48% |
| Net margin | 6.6% | 1.1% | ↑ | — |
| Free-cash-flow margin | 3.5% | 4.9% | ↓ | — |
| Return on invested capital | 8.6% | — | Top 37% | |
| Revenue growth, 3-year CAGR | -3.3% | — | Bottom 41% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.03×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -0.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.4%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +18.7 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -1.18×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 1.85%
- Net buyback yield (TTM)
- 1.00%
- Shareholder yield
- 2.84%
- Share count change, 1 year
- -1.3%
- Share count change, 3-year CAGR
- -0.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 7
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +12.9%
- Average 2-day reaction, last 8
- +0.6%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $110.00
- Target vs current price
- +12.9%
- Analysts with a rating
- 9
- Share rating Buy or Strong Buy
- 44%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | +21.0% | +1.4% | +8.7% | +9.8% | — |
| May 7, 2026 | +2.9% | -1.3% | +2.6% | +3.8% | +10.1% |
| Feb 17, 2026 | +19.0% | -0.5% | -8.8% | -21.3% | -7.1% |
| Nov 4, 2025 | +8.7% | -1.9% | +1.9% | +1.0% | +11.0% |
| Aug 5, 2025 | +7.7% | +1.7% | +2.3% | +9.8% | -5.2% |
| May 8, 2025 | +1.4% | +1.5% | -4.6% | -7.3% | -13.8% |
| Feb 18, 2025 | +3.7% | +1.6% | -5.7% | -8.3% | -16.4% |
| Nov 5, 2024 | +0.0% | +2.0% | +14.2% | +9.7% | +2.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | $1.27 | $1.05 | +21.0% | $491.4M |
| May 7, 2026 | $1.05 | $1.02 | +2.9% | $453.2M |
| Feb 17, 2026 | $1.50 | $1.26 | +19.0% | $455.6M |
| Nov 4, 2025 | $1.12 | $1.03 | +8.7% | $441.9M |
| Aug 5, 2025 | $1.26 | $1.17 | +7.7% | $439.7M |
| May 8, 2025 | $1.42 | $1.40 | +1.4% | $440.8M |
| Feb 18, 2025 | $1.41 | $1.36 | +3.7% | $466.8M |
| Nov 5, 2024 | $1.35 | $1.35 | +0.0% | $443.4M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 19.9× | 21.4× | 30th | Top 27% |
| P/E (forward) | 19.7× | — | — | — |
| EV / EBITDA | 12.8× | — | — | Top 45% |
| EV / Sales | 1.19× | — | — | Top 29% |
| Free-cash-flow yield | 2.70% | — | — | Bottom 43% |
| Earnings yield | 5.03% | — | — | Top 27% |
P/E over the past five years
Range 17.6× – 103.0× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +26.8%
- Earnings per share growth (TTM)
- +544.7%
- Change in P/E multiple
- -78.0%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 60
- Days above the 200-day average
- 94
- 50-day average slope (20 days)
- +5.4%
- 200-day average slope (20 days)
- +2.5%
- Distance from 50-day average
- +5.0%
- Distance from 200-day average
- +18.2%
- RSI (14)
- 61.5
- Relative volume
- 0.87×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 21.0%
- Volatility vs own 5-year history
- 6th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.95
- Correlation with S&P 500
- 0.53
- Current drawdown from 1-year high
- -1.3%
- Maximum drawdown, 3 years
- -49.9%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| May 15, 2024 | Mar 20, 2026 | -49.9% | 462 days | Not yet recovered |
| Apr 6, 2021 | Nov 30, 2021 | -23.4% | 166 days | 116 days (May 17, 2022) |
| May 17, 2022 | Oct 7, 2022 | -20.4% | 99 days | 24 days (Nov 10, 2022) |
| Feb 17, 2023 | May 31, 2023 | -19.9% | 70 days | 137 days (Dec 14, 2023) |
| Jan 12, 2021 | Jan 29, 2021 | -14.3% | 12 days | 17 days (Feb 24, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $2.40B
- P/E (TTM)
- 19.9
- EPS, diluted (TTM)
- $4.90
- Revenue (TTM)
- $1.84B
- Dividend yield
- 1.84%
- 52-week range
- $65.51 – $100.48
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.48B | $1.96B | $1.95B | $1.85B | $1.78B |
| Gross profit | $434.9M | $586.7M | $591.1M | $542.9M | $492.4M |
| Operating income | $132.1M | $187.3M | $161.6M | $177.9M | $156.3M |
| Net income | $93.1M | $133.0M | $139.1M | $35.6M | $116.6M |
| EPS (diluted) | $3.75 | $5.32 | $5.56 | $1.42 | $4.67 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $443.4M | $466.8M | $440.8M | $439.7M | $441.9M | $455.6M | $453.2M | $491.4M |
| Net income | $33.4M | -$70.4M | $32.8M | $23.5M | $12.9M | $47.4M | $30.4M | $30.8M |
| EPS (diluted) | $1.33 | -$2.82 | $1.31 | $0.94 | $0.52 | $1.91 | $1.22 | $1.25 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $93.2M | $81.7M | $207.3M | $184.5M | $138.3M |
| Capital expenditure | -$39.1M | -$42.3M | -$62.1M | -$41.4M | -$50.3M |
| Free cash flow | $54.1M | $39.4M | $145.2M | $143.1M | $88.0M |
| Dividends paid | -$28.8M | -$31.7M | -$35.1M | -$38.8M | -$42.4M |
| Net share buybacks | $9.3M | -$3.7M | -$200,000 | $1.4M | -$23.4M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $250.2M
- Total assets
- $1.85B
- Total liabilities
- $495.2M
- Total debt
- $47.9M
- Net debt
- -$202.3M
- Shareholders’ equity
- $1.34B
As of Jun 30, 2026 (filed Aug 5, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| May 19, 2026 | $0.92 | May 29, 2026 |
| Nov 18, 2025 | $0.87 | Nov 26, 2025 |
| May 20, 2025 | $0.84 | May 30, 2025 |
| Nov 18, 2024 | $0.79 | Nov 26, 2024 |
| May 17, 2024 | $0.76 | May 31, 2024 |
| Nov 17, 2023 | $0.72 | Nov 27, 2023 |
| May 19, 2023 | $0.69 | May 31, 2023 |
| Nov 18, 2022 | $0.65 | Nov 28, 2022 |
Short interest
- Shares sold short
- 511,052
- Days to cover
- 3.41
- Change vs previous report
- +9.5%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jul 23, 2007
- 2-for-1